Nursing care
Loop Diuretics: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Loop diuretics such as furosemide and bumetanide block sodium and chloride reabsorption in the loop of Henle, producing rapid, high-volume diuresis. They are first-line for fluid overload from heart failure, renal failure, or hepatic disease where thiazides are too weak. Give in the morning to protect sleep, and infuse IV doses slowly to avoid ototoxicity.
Why this drug and not another
Loop diuretics act on the thick ascending limb of the loop of Henle, the segment responsible for reabsorbing up to 25% of filtered sodium. Blocking it produces a diuresis far stronger than a thiazide can manage, which is why loop diuretics are the choice when a patient has pulmonary oedema, anasarca, or fluid overload that will not respond to a gentler agent.
They remain effective even when renal function is impaired, unlike thiazides, which lose potency as glomerular filtration rate falls. That makes furosemide or bumetanide the default in chronic kidney disease with volume overload, and in acute decompensated heart failure where rapid preload reduction is the goal. Bumetanide is roughly 40 times more potent by weight than furosemide, so doses are not interchangeable without recalculation.
Administration and timing
Give the morning dose early, and if a second dose is ordered, schedule it no later than early afternoon. A patient dosed in the evening will be up several times overnight to void, which disrupts sleep and increases fall risk, particularly in older adults getting out of bed in the dark.
IV push furosemide must be given slowly, generally no faster than 20 mg per minute, and bumetanide even more cautiously. Pushing it too fast is what drives the ototoxicity risk, not the drug itself at therapeutic doses. This matters more in patients already on other ototoxic agents such as aminoglycosides, and in those receiving high-dose IV therapy for refractory fluid overload. Oral formulations are less potent than IV milligram for milligram, so route changes require dose adjustment, not a straight substitution.
Monitoring parameters
Track daily weight at the same time each day, same scale, same clothing, since a 1 to 2 lb overnight change reflects fluid shift long before it shows on the chest x-ray or in lung sounds. Strict intake and output tells you whether the diuresis is keeping pace with the ordered goal.
Check serum potassium, sodium, magnesium, and renal function before and during therapy. Loop diuretics waste potassium and magnesium alongside sodium and water, so hypokalaemia and hypomagnesaemia are the expected companions of effective therapy, not incidental findings. Orthostatic blood pressure and heart rate catch volume depletion early, before the patient reports dizziness.
Adverse effects to report
Muscle cramps, weakness, and new cardiac dysrhythmia point to hypokalaemia or hypomagnesaemia and should be reported before the next dose is given. A flat or inverted T wave on telemetry is an early sign worth escalating rather than waiting for the morning labs.
Tinnitus, a sense of fullness in the ears, or hearing loss after an IV dose signals ototoxicity and the infusion rate is the first thing to review. Report it immediately, since the effect is usually reversible if caught early but can become permanent with continued rapid dosing. Also watch for signs of dehydration, hypotension, and in patients with sulfa sensitivity, a rash, since furosemide and bumetanide are sulfonamide derivatives.
Contraindications and cautions
Anuria is an absolute contraindication, since a diuretic cannot work on kidneys that are not producing urine, and the drug will simply accumulate. Known hypersensitivity to sulfonamides warrants caution, though the cross-reactivity risk with sulfonamide antibiotics is lower than once assumed and institutional policy varies on how strictly to avoid the drug class.
Use with care in patients on digoxin, since diuretic-induced hypokalaemia increases the risk of digoxin toxicity. Combine with an ACE inhibitor or ARB cautiously, watching for excessive hypotension, and adjust doses in hepatic cirrhosis where rapid diuresis can precipitate hepatic encephalopathy. Concurrent aminoglycoside therapy compounds ototoxicity risk and should prompt closer monitoring rather than automatic avoidance.
Teaching points the exam tests
NCLEX questions on loop diuretics usually centre on three things: morning dosing to protect sleep, slow IV push to prevent ototoxicity, and recognising hypokalaemia as the expected electrolyte complication. Expect a question that gives ringing in the ears after a rapid IV dose and asks what the nurse should have done differently.
Teach patients to rise slowly from sitting or lying to avoid orthostatic dizziness, to weigh themselves daily, and to report a weight gain of 2 to 3 lb in a day or 5 lb in a week. Reinforce that potassium-rich foods, such as bananas and leafy greens, support levels between labs, but do not replace potassium supplementation if it is prescribed.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Why are loop diuretics given in the morning?
Morning dosing keeps the diuretic effect concentrated during waking hours, so the patient is not woken repeatedly overnight to urinate. Sleep disruption from evening dosing also raises fall risk in older adults navigating to the bathroom in the dark.
What causes ototoxicity with furosemide?
Ototoxicity is linked to the rate of IV administration, not the drug at standard oral doses. Pushing furosemide too fast, especially at high doses or alongside other ototoxic drugs like aminoglycosides, raises the risk, so IV doses should be given slowly per protocol.
Do loop diuretics cause high or low potassium?
Low potassium. Loop diuretics block sodium and chloride reabsorption in the loop of Henle, which increases sodium delivery to the distal tubule and drives potassium excretion. Regular potassium monitoring and supplementation are standard with ongoing therapy.
Can furosemide be given to a patient with a sulfa allergy?
Furosemide is a sulfonamide derivative, so caution is warranted, though cross-reactivity with sulfonamide antibiotics is less common than traditionally taught. Confirm the nature of the prior reaction and follow institutional policy or prescriber guidance rather than withholding automatically.
What is the priority assessment before giving a loop diuretic?
Check the most recent potassium level, blood pressure, and urine output. Hold and notify the prescriber if the patient is hypotensive, has a potassium below the normal range without replacement ordered, or has documented anuria.
More on pharmacology
Guides on this